Cancer

Items 1751-1760 of 2225

per page
Set Descending Direction
  1. Nocardamine
    CAS  26605-16-3
    AG-CN2-0150
    AG-CN2-0150-M0011 mg
    CHF 150.00
    AG-CN2-0150-M0055 mg
    CHF 660.00
    Nocardamine
  2. Nocodazole
    CAS  31430-18-9
    AG-CR1-0019
    AG-CR1-0019-M0055 mg
    CHF 45.00
    AG-CR1-0019-M01010 mg
    CHF 70.00
    AG-CR1-0019-M02525 mg
    CHF 125.00
    AG-CR1-0019-M05050 mg
    CHF 230.00
    Nocodazole
  3. Notch1 (mouse):Fc (human) (rec.)
    AG-40B-0109
    AG-40B-0109-C05050 µg
    CHF 290.00
    AG-40B-0109-30503 x 50 µg
    CHF 575.00
  4. Notch2 (mouse):Fc (human) (rec.)
    AG-40B-0110
    AG-40B-0110-C05050 µg
    CHF 290.00
    AG-40B-0110-30503 x 50 µg
    CHF 575.00
  5. NSC697923
    CAS  343351-67-7
    AG-CR1-3519
    AG-CR1-3519-M0011 mg
    CHF 30.00
    AG-CR1-3519-M0055 mg
    CHF 70.00
    AG-CR1-3519-M02525 mg
    CHF 210.00
    NSC697923
  6. NU6102
    CAS  444722-95-6
    AG-CR1-0020
    AG-CR1-0020-M0011 mg
    CHF 65.00
    AG-CR1-0020-M0055 mg
    CHF 195.00
    NU6102
  7. NVP-BEZ235
    CAS  915019-65-7
    AG-CR1-3633
    AG-CR1-3633-M0055 mg
    CHF 30.00
    AG-CR1-3633-M02525 mg
    CHF 75.00
    NVP-BEZ235
  8. NVP-BGJ398
    CAS  872511-34-7
    SYN-1152
    SYN-1152-M0011 mg
    CHF 85.00
    SYN-1152-M0055 mg
    CHF 149.00
    SYN-1152-M01010 mg
    CHF 234.00
    SYN-1152-M05050 mg
    CHF 546.00
    SYN-1152-M100100 mg
    CHF 759.00
    NVP-BGJ398
  9. NVP-BSK805 dihydrochloride
    CAS  1092499-93-8 (free base)
    SYN-1136
    SYN-1136-M0011 mg
    CHF 234.00
    SYN-1136-M0055 mg
    CHF 355.00
    SYN-1136-M01010 mg
    CHF 497.00
    SYN-1136-M05050 mg
    CHF 1'348.00
    SYN-1136-M100100 mgINQ
    NVP-BSK805 dihydrochloride
  10. O-Phosphorylethanolamine
    CAS  1071-23-4
    CDX-C0021
    CDX-C0021-G02525 g
    CHF 81.00
    CDX-C0021-G100100 g
    CHF 285.00
    O-Phosphorylethanolamine

Items 1751-1760 of 2225

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.